BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27514463)

  • 1. Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of Statins.
    Ruaño G; Seip R; Windemuth A; Wu AH; Thompson PD
    Clin Lab Med; 2016 Sep; 36(3):473-91. PubMed ID: 27514463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.
    Ahangari N; Doosti M; Ghayour Mobarhan M; Sahebkar A; Ferns GA; Pasdar A
    Ann Med; 2020 Dec; 52(8):462-470. PubMed ID: 32735150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of cholesterol-lowering therapy.
    Schmitz G; Langmann T
    Vascul Pharmacol; 2006 Feb; 44(2):75-89. PubMed ID: 16337220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of lipid-lowering therapies.
    Hu M; Tomlinson B
    Pharmacogenomics; 2013 Jun; 14(8):981-95. PubMed ID: 23746191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic determinants of response to statins.
    Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of statins therapy.
    Puccetti L; Acampa M; Auteri A
    Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):228-36. PubMed ID: 18221122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of response to statins: where do we stand?
    Maitland-van der Zee AH; Boerwinkle E
    Curr Atheroscler Rep; 2005 May; 7(3):204-8. PubMed ID: 15811254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Statins in primary prevention: how to share the decision?].
    Nanchen D; Vonnez JL; Selby K; Auer R; Cornuz J
    Rev Med Suisse; 2015 Nov; 11(496):2222-6. PubMed ID: 26742352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin Prescribing in the Elderly: Special Considerations.
    Leya M; Stone NJ
    Curr Atheroscler Rep; 2017 Oct; 19(11):47. PubMed ID: 29019063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children Are Not Small Adults: Specific Findings in Statin Exposure and Response in a Growing Population.
    Wagner JB
    Clin Pharmacol Ther; 2019 Aug; 106(2):278-280. PubMed ID: 30970165
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Statin Plus Eicosapentaenoic Acid Combination Therapy for Cardiovascular Disease Prevention in Japanese Patients With Hypercholesterolemia - An Analysis Based on the Japan Eicosapentaenoic Acid Lipid Intervention Study (JELIS).
    Kodera S; Morita H; Kiyosue A; Ando J; Komuro I
    Circ J; 2018 Mar; 82(4):1076-1082. PubMed ID: 29367520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
    Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
    Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial-based approach to statin guidelines.
    Ridker PM; Wilson PW
    JAMA; 2013 Sep; 310(11):1123-4. PubMed ID: 23942579
    [No Abstract]   [Full Text] [Related]  

  • 15. microRNAs and response to statins in patients with hypercholesterolemia: from basic research to precision medicine.
    Zambrano T; Salazar LA
    Pharmacogenomics; 2018 Jun; 19(9):748-751. PubMed ID: 29785870
    [No Abstract]   [Full Text] [Related]  

  • 16. Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia.
    Sorich MJ; Wiese MD; O'Shea RL; Pekarsky B
    Pharmacoeconomics; 2013 May; 31(5):377-91. PubMed ID: 23568333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Statins for cardiovascular prevention: is there still a place for cholesterol measurement?].
    Scheen AJ; Kulbertus H
    Rev Med Liege; 2003 Apr; 58(4):191-7. PubMed ID: 12868320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in women for primary prevention--is there evidence to back up their use??
    Fenton A; Panay N
    Climacteric; 2010 Oct; 13(5):403-4. PubMed ID: 20738236
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients.
    Strandberg TE
    Curr Atheroscler Rep; 2019 May; 21(8):28. PubMed ID: 31111235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
    Lavie G; Cohen S
    Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.